Press Releases

Psychemedics Releases 2025 Workforce Insights Report

by
Psychemedics Corporation, a global leader in hair testing for drugs of abuse, today announced the release of its second annual Workforce Insights Report, providing a comprehensive look at the evolving drug landscape and its impact on workplace safety, hiring practices, and employer risk. The 2025 Psychemedics Insights Report draws from the largest proprietary database of ... Read more

Psychemedics Named “Most Innovative Drug Testing Company of the Year”

by
Psychemedics Corporation, the world’s leading provider of hair drug testing, is proud to announce it has been named “Most Innovative Drug Testing Company of the Year” by Acquisition International Magazine as part of its prestigious 2025 Global Excellence Awards. This recognition honors Psychemedics’ continued leadership in advancing the science of drug detection, including the recent ... Read more

Psychemedics Launches Groundbreaking Quartile Reporting for Enhanced Drug Testing Insights

by
Psychemedics Corporation, a global leader in hair drug testing, is proud to announce the launch of its innovative Quartile Reporting feature. This industry-first enhancement empowers organizations with unprecedented insights into drug test results, enabling data-driven decision-making and fostering safer, more productive workplaces. The new Quartile Reporting feature allows clients to see where a candidate’s or ... Read more

Psychemedics Corporation Announces Reverse and Forward Stock Split

by
DALLAS, TX December 2, 2024 (GLOBE NEWSWIRE) – Psychemedics Corporation (Nasdaq: PMD) (the “Company”), the world’s leading provider of hair testing for drugs of abuse, today announced that, following the approval of the Company’s stockholders at its Annual Meeting of Stockholders held on November 25, 2024, the Company’s Board of Directors has approved a 1-for-5,000 reverse ... Read more

Psychemedics Corporation Reminds Stockholders to Cast Their Votes for Upcoming Annual Meeting of Stockholders

by
Psychemedics Corporation (NASDAQ: PMD), a global leader in hair testing, reminds its stockholders to vote ahead of the Company’s upcoming annual meeting of stockholders scheduled for November 25, 2024.  Each stockholder’s vote is important.  The Company’s Board of Directors recommends that stockholders vote "FOR" each proposal at the annual meeting. Instructions for voting your shares ... Read more

Psychemedics Releases First-Ever Education Insights Report: Uncovering Drug Trends in Educational Institutions Through Hair Testing

by
Psychemedics Corporation (NASDAQ: PMD), a global leader in hair testing for drugs of abuse, is excited to announce the release of its first-ever Education Insights Report. This report provides an in-depth analysis of drug trends within educational institutions, shedding light on the growing challenges schools face in maintaining a drug-free environment for students and staff. ... Read more

Psychemedics Corporation Launches New Ketamine Hair Testing Service

by
Psychemedics Corporation (NASDAQ: PMD), a global leader in hair testing, is proud to announce the launch of its new ketamine hair testing solution. This innovative testing method marks a significant advancement in the detection and prevention for a drug-free workplace and community.  Ketamine, a powerful dissociative anesthetic and emerging drug of abuse, poses a growing ... Read more

Psychemedics Corporation’s Board of Directors Approves Plan to Terminate Registration of Its Common Stock

by
DALLAS, TX, August 12, 2024 – Psychemedics Corporation (Nasdaq:PMD) (“Psychemedics” or the “Company”) today announced that a Transaction Committee (the “Transaction Committee”) of the Board of Directors of the Company (the “Board”)  comprised of independent directors has recommended, and the Board has approved, a plan to cease the registration of the Company’s common stock under ... Read more

Psychemedics Recognized as a Top 10 Employee Health Testing Services Provider

by
Dallas, TX – March 21, 2024 Psychemedics Corporation (NASDAQ: PMD), a global leader in drug testing using hair analysis, is proud to announce its recognition as one of the Top 10 Employee Health Testing Services Providers for 2024 by ManageHR. This prestigious accolade highlights Psychemedics’ commitment to excellence and innovation in the field of employee ... Read more

Psychemedics Corporation Announces Relocation of Headquarters to Dallas, Texas

by
ACTON, Mass., January 2, 2024 Psychemedics Corporation, a global leader in hair testing for drugs of abuse, proudly announces the relocation of its corporate headquarters from Acton, Massachusetts, to Dallas, Texas, while reaffirming its unwavering dedication to delivering exceptional service and maintaining the highest standards in hair drug testing. The move to Dallas underscores Psychemedics’ ... Read more